METTL3 and osteoporosis: These results confirmed that the m6A methylation markedly contributes to the maintenance of osteogenesis as a whole, and overexpression of METTL3 and METTL14 in BMSCs has the potential to become a candidate for treating osteoporosis (Fig. 7B).